PC
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| The analysis of GSTA1 promoter genetic and functional diversity of human populations | Scientific reports |  | 2021 | 285 | 357 | ||
| Genetic Susceptibility to Hepatic Sinusoidal Obstruction Syndrome in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation | Biology of Blood and Marrow Transplantation |  | 2020 | 346 | 0 | ||
| Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantation | British Journal of Clinical Pharmacology | | 2018 | 378 | 217 | ||
| Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation | The Pharmacogenomics Journal | | 2018 | 527 | 284 | ||
| Development and validation of an allele-specific PCR assay for genotyping a promoter and exonic single nucleotide polymorphisms of MGMT gene | Journal of Biological Methods | | 2018 | 322 | 167 | ||
| GSTA1 Genetic Variants and Conditioning Regimen: Missing Key Factors in Dosing Guidelines of Busulfan in Pediatric Hematopoietic Stem Cell Transplantation | Biology of Blood and Marrow Transplantation | | 2017 | 501 | 17 | ||
| GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study | Oncotarget | | 2017 | 560 | 322 | ||
| Potential Predictive Biomarkers used to optimize treatments for Sinusoidal Obstruction Syndrome in pediatric Hematopoietic stem cell transplantation | Bulletin suisse du cancer | | 2016 | 453 | 1,796 | ||
| Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use | International Journal of Molecular Sciences | | 2016 | 587 | 604 | ||
| Creation of the Swiss group of pharmacogenomics and personalized therapy (SPT) | Paediatrica | | 2016 | 387 | 136 |
